1. Home
  2. NXL vs COOT Comparison

NXL vs COOT Comparison

Compare NXL & COOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • COOT
  • Stock Information
  • Founded
  • NXL 2010
  • COOT 2020
  • Country
  • NXL United States
  • COOT Australia
  • Employees
  • NXL N/A
  • COOT N/A
  • Industry
  • NXL Medical Specialities
  • COOT
  • Sector
  • NXL Health Care
  • COOT
  • Exchange
  • NXL Nasdaq
  • COOT NYSE
  • Market Cap
  • NXL 21.0M
  • COOT 20.2M
  • IPO Year
  • NXL 2022
  • COOT N/A
  • Fundamental
  • Price
  • NXL $0.99
  • COOT $0.65
  • Analyst Decision
  • NXL Strong Buy
  • COOT
  • Analyst Count
  • NXL 1
  • COOT 0
  • Target Price
  • NXL $5.00
  • COOT N/A
  • AVG Volume (30 Days)
  • NXL 87.1K
  • COOT 15.6K
  • Earning Date
  • NXL 08-07-2025
  • COOT 01-01-0001
  • Dividend Yield
  • NXL N/A
  • COOT N/A
  • EPS Growth
  • NXL N/A
  • COOT N/A
  • EPS
  • NXL N/A
  • COOT N/A
  • Revenue
  • NXL $131,065.00
  • COOT $23,640,002.00
  • Revenue This Year
  • NXL $79.59
  • COOT N/A
  • Revenue Next Year
  • NXL $334.65
  • COOT N/A
  • P/E Ratio
  • NXL N/A
  • COOT N/A
  • Revenue Growth
  • NXL N/A
  • COOT 30.48
  • 52 Week Low
  • NXL $0.59
  • COOT $0.61
  • 52 Week High
  • NXL $4.49
  • COOT $1.69
  • Technical
  • Relative Strength Index (RSI)
  • NXL 35.46
  • COOT 39.43
  • Support Level
  • NXL $0.95
  • COOT $0.63
  • Resistance Level
  • NXL $1.03
  • COOT $0.84
  • Average True Range (ATR)
  • NXL 0.08
  • COOT 0.03
  • MACD
  • NXL 0.00
  • COOT -0.01
  • Stochastic Oscillator
  • NXL 29.03
  • COOT 29.91

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About COOT AUSTRALIAN OILSEEDS HOLDINGS LTD

Australian Oilseeds Holdings Ltd through its subsidiaries, is focused on the manufacture and sale of chemical-free, non-GMO, sustainable edible oils and products derived from oilseeds. The company believes that transitioning from a fossil fuel economy to a renewable and chemical-free economy is the solution to many health problems the world is facing presently. Company's edible oil sales comprise of two segments: sales of bulk oils to wholesalers who use it as food ingredients or white labeling; sales of packaged oils as the company's own branding to supermarket channels. Sales of protein meals are bulk sales and mainly distributed to local farmers and feedlots as protein supplements.

Share on Social Networks: